Cladis Investment Advisory Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Interstate BancSystem
FIBK
|
+$982K |
| 2 |
Amazon
AMZN
|
+$622K |
| 3 |
GE HealthCare
GEHC
|
+$592K |
| 4 |
IBM
IBM
|
+$538K |
| 5 |
Rivian
RIVN
|
+$537K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kyndryl
KD
|
+$894K |
| 2 |
GE Aerospace
GE
|
+$641K |
| 3 |
DADA
Dada Nexus
DADA
|
+$429K |
| 4 |
AB InBev
BUD
|
+$369K |
| 5 |
Alibaba
BABA
|
+$290K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 12.02% |
| 3 | Consumer Discretionary | 10.28% |
| 4 | Industrials | 8.41% |
| 5 | Communication Services | 7.68% |
Similar funds
Cladis Investment Advisory's Q1 2023 Portfolio in Review
As of Q1 2023, Cladis Investment Advisory held 143 positions worth $111M, up 11% from $100M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Cladis Investment Advisory deployed $3.49M of net new capital in Q1 2023, opening 11 new positions and adding to 42 existing holdings. Its largest new stake was GE HealthCare: 8,287 shares worth $680K.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Kyndryl, an estimated $894K trimmed.
- Cladis Investment Advisory's largest Q1 2023 buy was GE HealthCare: 8,287 shares worth $680K.
- Cladis Investment Advisory added most to First Interstate BancSystem in Q1 2023, an estimated $982K increase.
- Cladis Investment Advisory's biggest Q1 2023 reduction was Kyndryl, cutting an estimated $894K.
- Cladis Investment Advisory fully exited AB InBev in Q1 2023, selling an estimated $369K.
- Cladis Investment Advisory's ten largest holdings make up 29% of its $111M portfolio in Q1 2023.
- Cladis Investment Advisory opened 11 new positions and closed 4 in Q1 2023.
- Cladis Investment Advisory's portfolio value rose 11% quarter-over-quarter to $111M.
Based on Cladis Investment Advisory's 13F filing for Q1 2023, filed 15 May 2023.